Medical Uses, Efficacy, and Patient Safety Click here to listen to this article Share via The FDA approved new peptide medications in 2024 and 2025, including treatments for hypoparathyroidism and Barth syndrome
That's the standard we hold ourselves to, and it's the standard we believe the entire research community should embrace
The rationale is that effects accumulate during the course and persist between courses, with new courses reinforcing the previous effects
Normal, young human somatic cells have relatively long telomeres, which shorten by up to 70 bp per year, due to the end replication problem (Yik et al
aemia, certain gut surgeries, or dietary restrictions
9. Meister, A., and Anderson, M.E